Stock Price Movement and Market Context
On 19 Feb 2026, TTK Healthcare’s share price declined by 0.65%, closing at Rs.923.45, the lowest level in the past year. This drop occurred in tandem with a sharp reversal in the broader market, where the Sensex fell by 1,471.68 points (-1.48%) to 82,498.14 after opening 235.57 points higher. Despite the Sensex being only 4.44% below its 52-week high of 86,159.02, TTK Healthcare’s performance has lagged significantly.
The stock is currently trading below its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages, signalling a sustained downtrend. This contrasts with the Sensex, which, while trading below its 50-day moving average, still maintains a 50DMA above its 200DMA, indicating a more stable medium-term trend for the benchmark index.
Long-Term and Recent Performance Metrics
Over the last year, TTK Healthcare has delivered a negative return of -22.10%, markedly underperforming the Sensex’s positive 8.64% gain over the same period. The stock has also underperformed the BSE500 index across multiple time frames, including the last three years, one year, and three months, reflecting persistent challenges in maintaining competitive growth.
Its 52-week high was Rs.1,402, indicating a substantial decline of approximately 34% from that peak. This performance gap highlights the stock’s relative weakness within the diversified sector and the broader market.
This week's disclosed pick, a Large Cap from NBFC, comes with precise Target Price and analysis. Check if you're positioned right for this opportunity!
- - Precise target price set
- - Weekly selection live
- - Position check opportunity
Financial Performance and Profitability Trends
TTK Healthcare’s financial growth has been modest over the past five years, with net sales increasing at an annualised rate of 6.99% and operating profit growing at 15.42%. These figures suggest steady but unspectacular expansion, which has not translated into strong stock performance.
In the most recent half-yearly results, cash and cash equivalents stood at Rs.600.89 crores, the lowest level recorded in recent periods. The debtors turnover ratio also declined to 7.40 times, indicating slower collection efficiency. Notably, non-operating income accounted for 80.43% of profit before tax in the latest quarter, underscoring a reliance on income sources outside core operations.
Shareholding and Market Perception
Despite the company’s sizeable market presence, domestic mutual funds hold a minimal stake of just 0.01%. Given that mutual funds typically conduct thorough research and maintain significant holdings in fundamentally strong companies, this low level of institutional interest may reflect reservations about the stock’s valuation or business prospects at current prices.
Valuation and Return Ratios
TTK Healthcare maintains a low average debt-to-equity ratio of zero, indicating a conservative capital structure with limited leverage. The return on equity (ROE) stands at 6.5%, which is moderate but below levels typically associated with high-growth companies.
The stock trades at a price-to-book value of 1.2, suggesting an attractive valuation on a book value basis. However, it is priced at a premium relative to its peers’ historical averages. Over the past year, while the stock’s price declined by 22.10%, profits increased marginally by 2.4%, resulting in a high price/earnings-to-growth (PEG) ratio of 8.1, which may indicate overvaluation relative to earnings growth.
Holding TTK Healthcare Ltd. from Diversified? See if there's a smarter choice! SwitchER compares it with peers and suggests superior options across market caps and sectors!
- - Peer comparison ready
- - Superior options identified
- - Cross market-cap analysis
Summary of Key Metrics and Market Standing
TTK Healthcare currently holds a Mojo Score of 37.0 with a Mojo Grade of Sell, downgraded from Hold on 21 Jul 2025. The company’s market capitalisation grade is 4, reflecting its mid-tier size within the diversified sector. The stock’s recent price action and fundamental metrics indicate a cautious stance from the market, with the share price reflecting concerns over growth and profitability.
While the company’s conservative debt profile and moderate ROE provide some stability, the combination of subdued sales growth, reliance on non-operating income, and limited institutional interest have contributed to the stock’s decline to its 52-week low.
Market Environment and Sector Comparison
TTK Healthcare’s performance today was in line with its sector peers, which have also faced pressure amid the broader market correction. The diversified sector has experienced mixed results, with some companies maintaining upward momentum while others, like TTK Healthcare, have seen share prices retreat.
The Sensex’s sharp reversal after a positive opening underscores the prevailing volatility in the market, which has affected stocks across sectors. Despite this, the benchmark index remains relatively close to its 52-week high, highlighting the divergence between the broader market and TTK Healthcare’s stock trajectory.
Conclusion
TTK Healthcare Ltd.’s fall to Rs.923.45 marks a notable low point in its share price over the past year, reflecting a combination of modest growth, valuation concerns, and limited institutional backing. The stock’s position below all major moving averages and its underperformance relative to the Sensex and sector peers illustrate the challenges it faces in regaining upward momentum. Investors and market participants will continue to monitor the company’s financial results and market developments to assess its trajectory within the diversified sector.
Limited Period Only. Start at Rs. 9,999 - Get MojoOne for 1 Year + 3 Months FREE (60% Off) Get 71% Off →
